Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLM2019 vs Wegovy in adult obesity
CTR20255180Phase 3Active
- Sponsor
- Qilu Pharmaceutical
- Start
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of QLM2019 in obesity, sponsored by Qilu Pharmaceutical. Started Jan 2026; status: active.
02
Drugs
QLM2019
03
Conditions
obesity
Beyond the preview
Go deeper on CTR20255180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255180.